Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women

CONTEXT: Studies suggest that menopausal hormone therapy (MHT) prevents type 2 diabetes (T2D). The combination of conjugated estrogens (CE) with the selective estrogen receptor modulator bazedoxifene (BZA) is an MHT that improves obesity and T2D in preclinical models of menopausal metabolic syndrome...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Endocr Soc
Prif Awduron: Lovre, Dragana, Peacock, Erin, Katalenich, Bonnie, Moreau, Cynthia, Xu, Beibei, Tate, Chandra, Utzschneider, Kristina M, Gautier, Jean-François, Fonseca, Vivian, Mauvais-Jarvis, Franck
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Endocrine Society 2019
Pynciau:
Clinical Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6676076/
https://ncbi.nlm.nih.gov/pubmed/31384719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00074
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg